| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/27/2003 | WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015656A2 Oral care substance delivery strip |
| 02/27/2003 | WO2003015606A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 02/27/2003 | WO2003015516A1 Compositions and methods for treatment of mitochondrial diseases |
| 02/27/2003 | WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | WO2003015494A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002100851A3 Thiophene derivatives as antiviral agents for flavivirus infection |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002094180A3 Pharmaceutically active isoindoline derivatives |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002089740A3 Sulfonamides |
| 02/27/2003 | WO2002074042A3 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 02/27/2003 | WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/27/2003 | WO2002064590A3 Carboline derivatives |
| 02/27/2003 | WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2002018403A1 Process for producing erythromycin derivative |
| 02/27/2003 | WO2002002797A3 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 02/27/2003 | US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof |
| 02/27/2003 | US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS) |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040530 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containning them |
| 02/27/2003 | US20030040528 For relieving or preventing constipation in a human constipated patient or preparing a bowel prior to preventative, diagnostic or surgical procedures |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases |
| 02/27/2003 | US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 02/27/2003 | US20030040509 Methods and compositions for treating diseases associated with excesses in ACE |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040464 Method of treating or preventing attention defecit hyperactivity disorder |
| 02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039740 Composition for enteral nutrition comprising fibres |
| 02/27/2003 | US20030039706 Plant extracts |
| 02/27/2003 | US20030039687 Using Carbomer |
| 02/27/2003 | US20030039684 Preparation of a directly mouldable tabletting auxiliary |
| 02/27/2003 | US20030039683 Multilayer binding; lamellar surface structure |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039629 Espression enhancer for protein synthesis inhibitory genes |
| 02/27/2003 | US20030039626 Fat-binding polymers |
| 02/27/2003 | US20030039616 Antimicrobial flavor and oral care composition containing the same |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458068A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | CA2457781A1 Kgf polypeptide compositions |
| 02/27/2003 | CA2457644A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457453A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2457330A1 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | CA2457164A1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 02/27/2003 | CA2457086A1 Oral care substance delivery strip |
| 02/27/2003 | CA2457055A1 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 02/27/2003 | CA2456743A1 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456150A1 Selective estrogen receptor modulators |
| 02/27/2003 | CA2455793A1 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| 02/27/2003 | CA2454083A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
| 02/27/2003 | CA2453647A1 1-alkyl 0r 1-cycloalkyltriazolo¬4,3-a|quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/27/2003 | CA2452801A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 02/26/2003 | WO2002020467A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)-[n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient |
| 02/26/2003 | WO2002020010A1 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions |
| 02/26/2003 | EP1285947A1 Antimicrobial composition |
| 02/26/2003 | EP1285922A1 1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/26/2003 | EP1285916A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNF alpha levels |
| 02/26/2003 | EP1285663A1 Preventives for reinfection after liver transplantation |
| 02/26/2003 | EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/26/2003 | EP1285652A1 Novel fatty acid analogues for the treatment of hypertension |
| 02/26/2003 | EP1285271A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285063A1 Anti-angiogenic polypeptides |
| 02/26/2003 | EP1285001A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and integrin alpha.v.beta.3 and medical use thereof |
| 02/26/2003 | EP1284977A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 02/26/2003 | EP1284974A2 Triazolyl tropane derivatives as ccr5 modulators |
| 02/26/2003 | EP1284973A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 02/26/2003 | EP1284963A1 Novel calcium receptor active molecules and method for preparing same |
| 02/26/2003 | EP1284960A1 Cyclic amino acid derivatives useful as pharmaceutical agents |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284952A1 Substituted chalcones as therapeutic compounds |
| 02/26/2003 | EP1284753A2 Combination of growth hormone secretagogues and antidepressants |
| 02/26/2003 | EP1284741A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 02/26/2003 | EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds |
| 02/26/2003 | EP1284732A2 Method for treating functional dyspepsia using alosetron |
| 02/26/2003 | EP1284728A1 Pharmaceuticals for treating obesity |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP1284723A1 Compositions and therapies for hyperlipidaemia-associated disorders |
| 02/26/2003 | EP1284720A2 Method of treating hepatitis delta viral infection |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP1153615B1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 02/26/2003 | EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 02/26/2003 | EP1042324B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |